Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00830453 · ClinicalTrials.gov registry record · Phase 2
Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury
A Phase 2 study, sponsored by Intermountain Health Care.
- Completed
- Registry status
- Phase 2
- Development phase
- 63
- Enrollment target
NCT00830453 is a Phase 2 study that has completed, run by Intermountain Health Care. The registered enrollment target is 63 participants.
The verdict
NCT00830453, a Phase 2 study, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 63 participants
- Enrollment target
Study Summary
The purpose of this study is to discover the feasibility of conducting clinical research in individuals with chronic sequelae following brain injury who are given hyperbaric oxygen. This study will also look at the outcome of individuals with a chronic stable brain injury due to trauma, anoxia (lack of oxygen to the brain), or stroke, who are given hyperbaric oxygen. Outcome measures testing cognitive (memory, etc.) and functional (balance, strength, etc.) measures will be performed before the hyperbaric sessions, immediately following them, and 6 months later. The subject will receive 60 hyperbaric sessions, 60 minutes in the chamber, to a pressure of 1.5 ATA, once daily, Monday through Friday.
Interventions
- PROCEDURE Hyperbaric oxygen therapy (HBO2)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2003-11 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00830453
The ClinicalTrials.gov registry entry for NCT00830453 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Intermountain Health Care, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hyperbaric oxygen therapy (HBO2) is the first listed.
NCT00830453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00830453 about?
NCT00830453 is a clinical study titled "Hyperbaric Oxygen Therapy in Chronic Stable Brain Injury". The purpose of this study is to discover the feasibility of conducting clinical research in individuals with chronic sequelae following brain injury who are given hyperbaric oxygen. This study will also look at the outcome of individuals with a chronic stable brain injury due to trauma, anoxia (lack...
What is the current status of trial NCT00830453?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 63 participants. The study started on 2003-11. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00830453?
The interventions under investigation include: Hyperbaric oxygen therapy (HBO2) (PROCEDURE).
Who is sponsoring clinical trial NCT00830453?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.